LABB.MX : Summary for GENOMMA LAB INTERNACIONAL, S.A. - Yahoo Finance

U.S. Markets close in 2 hrs 37 mins

Genomma Lab Internacional, S.A.B. de C.V. (LABB.MX)


Mexico - Mexico Delayed Price. Currency in MXN
Add to watchlist
20.07-0.13 (-0.64%)
As of 11:59AM CST. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close20.20
Open20.30
Bid20.09 x 50000
Ask20.15 x 194200
Day's Range20.00 - 20.31
52 Week Range9.90 - 25.47
Volume336,170
Avg. Volume1,880,683
Market Cap19.6B
Beta0.07
PE Ratio (TTM)-35.65
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Bloomberg7 months ago

    Acne Killer Genomma Tumbles After Report Former Unit Probed

    Genomma Lab Internacional SAB, the Mexican seller of remedies for acne and baldness, fell the most in eight months after a news report that a drug distributor in which the company sold a majority stake ...

  • Mexico Drug Seller's 39-Year-Old CEO Has Plan to Stem 65% Rout
    Bloomberglast year

    Mexico Drug Seller's 39-Year-Old CEO Has Plan to Stem 65% Rout

    Genomma Lab Internacional SAB, the Mexican drug company whose shares are trading near a six-year low, is scrapping about 20 lesser-known brands as part of an effort to streamline operations and grow abroad ...

  • Bloomberglast year

    Zit Zapper’s Shopping Spree Ends as Mexico Salve Maker Cuts Debt

    Chief Executive Officer Rodrigo Herrera, whose family holds about 30 percent of the shares, said in an interview that Genomma plans to license out at least 15 brands and use the extra cash to pay down debt and buy back shares. “The best investment that we can make is in our own company, and not do any acquisitions right now,” Herrera said in an interview Friday. The CEO is changing tack after his company’s stock tumbled 41 percent this year, the worst performance on Mexico’s benchmark IPC gauge.